Treatment Ebola virus cases in the United States

1 treatment

1.1 biocontainment units in u.s.
1.2 experimental treatments
1.3 experimental preventative vaccines

treatment
biocontainment units in u.s.

corridor of nih special clinical studies unit, specialized biocontainment unit. negative-pressure anterooms on left lead negative-pressure patient rooms (not shown in picture).

the united states has capacity isolate , manage 11 patients in 4 specialized biocontainment units. these include university of nebraska medical center in omaha, nebraska, national institutes of health in bethesda, maryland, st. patrick hospital , health sciences center in missoula, montana , emory university hospital in atlanta, georgia.

experimental treatments

there yet no fda-approved medication or vaccine. director of national institute of allergy , infectious diseases, dr. anthony fauci, has stated scientific community still in stages of understanding how infection ebola virus can treated , prevented. there no cure or specific treatment approved. however, survival improved supportive care rehydration , symptomatic treatment. treatment supportive in nature. number of experimental treatments being considered use in context of outbreak, , or undergo clinical trials.

in late august 2014, both kent brantly , nancy writebol became first people given experimental drug zmapp. both recovered, there no confirmation or proof drug factor. spanish priest ebola had taken zmapp died afterward. until time, zmapp had been tested on primates , looked promising, causing no serious side effects , protecting animals infection. bill & melinda gates foundation has donated $150,000 amgen increase production, , u.s. department of health , human services has asked number of centers increase production.

there have been @ least 2 promising treatments infected. first brincidofovir, experimental antiviral drug, given duncan, mukpo, , spencer.

treatment using transfusion of plasma ebola survivors, form of “passive immunotherapy,” since contains antibodies able fight virus, has been used apparent success on number of patients. survivor kent brantly donated blood rick sacra, ashoka mukpo , nurse nina pham. world health organization (who) has made priority try treatment, , has been telling affected countries how it.

experimental preventative vaccines

many ebola vaccine candidates had been developed in decade before 2014, none has yet been approved clinical use in humans. several promising vaccine candidates have been shown protect nonhuman primates (usually macaques) against lethal infection, , going through clinical trial process.

in late october 2014, canada planned ship 800 vials of experimental vaccine world health organization (who) in geneva, drug having been licensed newlink genetics corporation, of iowa. british drugmaker glaxosmithkline announced had expedited research , development of vaccine, which, if successful, available in 2015. although s still unknown ones approved, hopes have millions of vaccine doses ready sometime in 2015, , expects 5 more experimental vaccines start being tested in march 2015.